News
26 Feb 2007
Taylor joins DLA Piper’s Intellectual Property practice in San Diego
Press Release
(San Diego) – DLA Piper US LLP announced that Stacy Taylor has joined the firm’s Intellectual Property practice group as a partner in the firm’s San Diego office. She comes to DLA Piper from Foley & Lardner LLP.
Taylor focuses her practice on worldwide patent prosecution, trademark registration, licensing and litigation of administrative actions before the United States Patent and Trademark Office. She has extensive experience handling intellectual property matters in such areas as immunology, cellular therapies, gene therapy, molecular biology, drug development and medical devices. Taylor also secures, manages and enforces trademarks for pharmaceutical and consumer products companies.
“Stacy will play a key role in expanding our biotech patent capabilities both in our San Diego office and throughout the firm,” said Dan Christenbury, chair of the firm’s Patent Prosecution practice group. “She will also drive a variety of new business opportunities, pursuing both domestic and international engagements for trademark registration and enforcement, licensing and corporate work, franchise matters, FDA work and patent interference litigation.”
“Stacy is an exceptional attorney with over two decades of experience in the field,” said Lisa Haile, co-chair of the firm’s Life Sciences practice group. “Her addition will accelerate the growth of our Life Sciences practice and help build on our already strong Emerging Growth and Venture Capital practice.”
Taylor represents large academic institutions, as well as for-profit commercial enterprises, with a particular emphasis on start-up ventures. In addition, she co-founded Endicor Medical, Inc., a privately funded corporation specializing in the development and manufacture of medical devices for use in cardiac and peripheral vascular surgery.
Taylor is a member of the International Trademark Association, the Association of University Technology Managers, the Licensing Executives Society, the American Intellectual Property Law Association and the San Diego Lawyer’s Club.
She received a J.D., cum laude, from California Western School of Law, and a B.A. with honors from California Polytechnic State University in biological sciences, with a minor in chemistry.
DLA Piper’s U.S. Patent Prosecution practice group is comprised of more than 50 patent lawyers, located in the Chicago, Philadelphia, Northern Virginia, San Diego, San Francisco, Silicon Valley, Los Angeles and Washington, D.C. offices. The firm’s attorneys are experienced in patent litigation and licensing, as well as the intricacies of patent application drafting and prosecution.
The firm’s U.S. Life Sciences practice group advises clients in all stages of growth, from start-ups to Fortune 500 companies. DLA Piper attorneys have significant experience representing leading life sciences investors, including venture capital firms, entrepreneurs, and financial institutions as well as some of the leading non-profit institutes in the United States and worldwide. The group consists of more than 100 attorneys based in Baltimore, Boston, San Diego, Silicon Valley, Raleigh, Seattle, Philadelphia, Texas and Washington, D.C.
About DLA Piper DLA Piper has 3,200 lawyers in 24 countries and 63 offices throughout the U.S., U.K., Continental Europe, Middle East and Asia. It has leading practices in corporate, finance, human resources, litigation, real estate, regulatory and legislative, tax, and technology, media and communications. In certain jurisdictions, this information may be considered attorney advertising.
###
CONTACTS:
Dan Christenbury, Chair, Patent Prosecution practice, DLA Piper, 215.656.3381
Lisa Haile, Co-Chair, Life Sciences practice, DLA Piper, 858.677.1456
Kristen Griffin, Media Relations, GreenTarget Global Group, 312.252.4107
This information is intended as a general overview and discussion of the subjects dealt with. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. DLA Piper is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.
Copyright © 2012 DLA Piper. All rights reserved.